32 / 112
30
Scientific Programme
|
Monday, 15 June 2015
WFSBP 2015
Forum-01
Forum
13:00–14:30
Kokkali Room
Achieving interaction among Greek scientists involved
in Biological Psychiatry worldwide
Chair:
Nikos C. Stefanis, Greece
Co-Chair: Antonis Politis, Greece
Secretaries: Alexander Hatzimanolis, Greece
Rigas Soldatos, Greece
Presenters: V. Brakoulias, Australia
P.T. Daniolos, USA
M. Filiou, Germany
A. Halaris, USA
C. Lyketsos, USA
M. Mavrikaki, USA
K. Patas, Germany
C. Pantelis, Australia
G. Petrides, USA
C. Phassouliotis, Australia
Y. Trakadis, Canada
D. Velakoulis, Australia
N. Venizelos, Sweden
Discussion among all participants
ES-01
Educational Session
14:00–18:00
MC 3.3 Room
Session 1 on basic research issues
Chairs:
Florence Thibaut, France
Tudor Udristoiu, Romania
Co-Chairs: Victoria Valdez de Vuibert, Ecuador
Anu Kant Mital, India
ES-01-001
What do we learn from genetics (the example of schizo-
phrenia)
Florence Thibaut, France
ES-01-002
What do we learn from genetics (the example of schizo-
phrenia)
Dan Rujescu, Germany
ES-01-003
What do we learn from pharmacology (the example of
anxiolytics mechanism of action)
Michel Bourin, France
ES-01-004
Biomarkers in psychiatry
Peter Riederer, Germany
ES-01-005
What do we learn from meta-analysis
Alessandro Serretti, Italy
ES-01-006
Meta-analysis of treatments for anxiety disorders
Borwin Bandelow, Germany
ES-01-007
Structural, functional and molecular brain imaging in psy-
chiatry
Rupert Lanzenberger, Austria
ES-01-008
How to get grants and publish papers
Siegfried Kasper, Austria
FC-01
Free Communications
08:30–10:00
Kokkali Room
Schizophrenia
Chair:
Brian Dean, Australia
Co-Chair: Nikos C. Stefanis, Greece
FC-01-001
Social brain activity during theory of mind in first episode
psychosis: Comparison with healthy controls and link to
symptoms
Cali Bartholomeusz, Australia
E. Ganella, S. Whittle, A. Abu-Akel, K. Allott, A. Thompson,
P. McGorry, E. Killackey, C. Pantelis, S. J. Wood
FC-01-002
Genetic influences on multivariate cognitive endopheno-
types of positive symptom schizophrenia
Narayan R. Mutalik, India
H. HN, S. Jain, J. P. John
FC-01-003
Ketamine as a model for schizophrenia deficits
Erica Neill, Australia
S. Rossell, C. Morgan, O. Carter, N. Joshua
FC-01-004
Prefrontal glutamate and cortical structure in schizophrenia:
A combined brain metabolic and neuroanatomical study
in antipsychotic naïve patients
Carl Christoph Schultz, Germany
A. Gussew, I. Nenadic, H. Sauer, S. Smesny
FC-01-005
Similar age-related decline in cortical activity over fronto-
temporal regions in schizophrenia: A multi-channel near-
infrared spectroscopy study
Po Han Chou, Taiwan
S. Koike, Y. Nishimura, Y. Satomura, A. Kinoshita, R. Taki-
zawa, K. Kasai